Global Digital Twin Market Growth is forecasted to be driven by increasing demand for personalized therapies and digitization trends

A digital twin is a virtual replica of a physical object or a process. Real world data collected through sensors is fed into virtual model. The digital twin then offers the real-time view in a 3D visual format. The real-time insights help prevent bad decisions, conduct preventive measures and reduce any future untoward incidents. Healthcare is rapidly embracing digital twin technology. The goal of this trend is to deliver data-driven personalized medicine as well as accelerate medical innovation. Global Digital Twin market is driven by huge infusion of funds by government as well as venture capital firms; growing cancer, genetic, and rare disorder research; rising healthcare digitization; growing demand for personalized/precision medicine; and increasing focus of healthcare organization on curtailing burgeoning cost, improve workflow and patient care.

Medi-Tech Insights’ research report on Digital Twin market analyses the market with respect to product (software and services), application, end user, and geography

Based on our research & interviews with industry experts, it is evident that asset and process management, personalized medicine, surgical planning, and drug discovery (including clinical trials) are the major applications of Digital Twin market today, while US is the largest geographic market.

Get Customized Report on Digital Twin Market @ https://meditechinsights.com/healthcare-digital-twin-market/

The Digital Twin market is evolving and currently driven by start-ups/small size companies offering application specific solutions

The Digital Twin market is at nascent stage and took upward momentum after COVID-19 pandemic. The market comprises various start-ups/small players offering solutions for specific applications. For instance, Sim&Cure is France-based start-up offering patient-based digital twin for treating aneurysms. Further, ophthalmology start-up Optimo Medical is a Switzerland-based digital solutions company offering digital twin solution for planning eye surgery for astigmatism. Some of the large and small players operating in the Digital Twin market include General Electric, Ansys, Atos, Dassault Systems (3DS Company), Microsoft, Philips Healthcare, Siemens, HP, Twin Health, Verto Health, Fasttream Technologies, ThoughtWire, Sim&Cure, and Optimo Medical, among others.

“Medical device manufacturers are increasingly adopting digital twins to model devices as well as patients to treat people with specific conditions. The journey of digital twins in healthcare has just begun and its future is nearly infinite”- CEO, Whole Body Digital Twin Solution Provider

Medi-Tech Insights’ latest report analyses key industry segments such as investment trends and emerging opportunities in the Digital Twin market.

Healthcare organizations, investors, and regulatory authorities are increasingly recognizing the importance of digital twin solutions in improving patient care. Drawn by the huge promise to disrupt healthcare, many VCs/investors have backed companies in Digital Twin market. For instance, in October 2021, Twin Health, makers of the Whole Body Digital Twin precision health technology raised $140 million in Series C funding. At present, the digital twin solution is addressing diseases such as diabetes, hypertension, and some other metabolic diseases. Similarly, US-based Unlearn has developed DiGenesis, a machine-learning platform that generates control patient data for clinical studies. In April 2020, the company secured a $12 million Series A financing. Such funding's will instill the impetus for development and adoption of digital twin technology in healthcare.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more

Global Drug Discovery Software market valued at $2 billion in 2020, is projected to grow at a healthy CAGR of 14% to reach $3.5 billion by 2025

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe
Read more